BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12547291)

  • 1. A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression.
    Barbee JG; Billings CK; Bologna NB; Townsend MH
    J Affect Disord; 2003 Feb; 73(3):229-36. PubMed ID: 12547291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (Generalized Anxiety and Depression Impact Survey II).
    Ansseau M; Fischler B; Dierick M; Albert A; Leyman S; Mignon A
    Depress Anxiety; 2008; 25(6):506-13. PubMed ID: 17595015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study.
    Ansseau M; Fischler B; Dierick M; Mignon A; Leyman S
    Eur Psychiatry; 2005 May; 20(3):229-35. PubMed ID: 15935421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal memory predicts treatment outcome in syndromal anxious depression: An iSPOT-D report.
    Braund TA; Tillman G; Palmer DM; Harris AWF
    J Affect Disord; 2020 Jan; 260():245-253. PubMed ID: 31513968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comorbidity of anxiety and depression.
    Rodney J; Prior N; Cooper B; Theodoros M; Browning J; Steinberg B; Evans L
    Aust N Z J Psychiatry; 1997 Oct; 31(5):700-3. PubMed ID: 9400876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder.
    Beesdo K; Pine DS; Lieb R; Wittchen HU
    Arch Gen Psychiatry; 2010 Jan; 67(1):47-57. PubMed ID: 20048222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of symptoms of generalized anxiety disorder on the course of late-life depression.
    Steffens DC; McQuoid DR
    Am J Geriatr Psychiatry; 2005 Jan; 13(1):40-7. PubMed ID: 15653939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
    Mittal D; Fortney JC; Pyne JM; Wetherell JL
    J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of the Symptom Checklist SCL-90 to differentiate various anxiety and depressive disorders.
    Kennedy BL; Morris RL; Pedley LL; Schwab JJ
    Psychiatr Q; 2001; 72(3):277-88. PubMed ID: 11467161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
    Ongur D; Farabaugh A; Iosifescu DV; Perlis R; Fava M
    Psychother Psychosom; 2005; 74(3):173-8. PubMed ID: 15832068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden.
    Nilsson J; Östling S; Waern M; Karlsson B; Sigström R; Guo X; Skoog I
    Am J Geriatr Psychiatry; 2012 Nov; 20(11):963-72. PubMed ID: 22549369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
    Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
    Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized anxiety disorder: is there any specific symptom?
    Faravelli C; Castellini G; Benni L; Brugnera A; Landi M; Lo Sauro C; Pietrini F; Rotella F; Ricca V
    Compr Psychiatry; 2012 Nov; 53(8):1056-62. PubMed ID: 22578985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program.
    Salzman C; Goldenberg I; Bruce SE; Keller MB
    J Clin Psychiatry; 2001 Mar; 62(3):149-52. PubMed ID: 11305698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual anxiety symptoms in depressed primary care patients.
    McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
    J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample.
    Kendler KS; Gardner CO; Gatz M; Pedersen NL
    Psychol Med; 2007 Mar; 37(3):453-62. PubMed ID: 17121688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.